item1.txt
The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June.
The Company early-adopted ASU 2017-12 in the first quarter of fiscal year 2018.
There was no material change to the Company's consolidated financial statements as a result of this adoption.
The amendments in this standard are effective beginning in the first quarter of fiscal year 2019, with early adoption permitted, including adoption in any interim period for which financial statements have not yet been issued.
The Company is currently evaluating the potential impact of this standard on its consolidated financial statements.
This standard provides guidance about the reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act. ASU 2018-02 is effective for the Company in the first quarter of fiscal year 2019, with early adoption permitted, including adoption in any interim period for which financial statements have not yet been issued.
The Company does not believe the implementation of this standard will result in a material impact to its consolidated financial statements.
The Company's Level 3 assets and liabilities consist of contingent consideration liabilities related to an acquisition during the three months ended March 31, 2018.
During the nine months ended March 31, 2018 and the year ended June 24, 2017, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.
In the nine months ended March 31, 2018 and the year ended June 24, 2017, the Company did not recognize any impairment charges on short-term investments.
The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Euro, Indian Rupee, Japanese Yen, Taiwan New Dollar, South Korean Won, and Chinese Yuan, expenditures for sales offices and research and development activities undertaken outside of the U.S. The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) No. 815-Derivatives and Hedging (“ASC 815”).
As of March 31, 2018 and June 24, 2017, the notional amounts of the forward contracts the Company held to purchase international currencies were $37.3 million and $36.2 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $0.6 million and $0.2 million, respectively.
The debt indentures that govern the 2027 Notes, the 2023 Notes and the 2018 Notes, respectively, include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future.
Amortized discount and expenses, as well as interest expense associated with the notes, were $12.4 million and $7.9 million during the three months ended March 31, 2018 and March 25, 2017, respectively.
Amortized discount and expenses, as well as interest expense associated with the notes, were $37.1 million and $26.3 million during the nine months ended March 31, 2018 and March 25, 2017, respectively.
The estimated fair value of the Company’s outstanding debt obligations was approximately $1,485 million as of March 31, 2018.
The Company recorded interest expense of $12.5 million and $8.1 million during the three months ended March 31, 2018, and March 25, 2017, respectively.


item2.txt
Net revenues were $648.6 million and $581.2 million for the three months ended March 31, 2018 and March 25, 2017, respectively.
Net revenues were $1,846.9 million and $1,693.6 million for the nine months ended March 31, 2018 and March 25, 2017, respectively.
During the three months ended March 31, 2018 and March 25, 2017, approximately 88% and 89% of net revenues, respectively, were derived from customers outside of the United States.
The impact of changes in foreign exchange rates on our revenue and results of operations for the three and nine months ended March 31, 2018 and March 25, 2017 was immaterial.
Our gross margin percentages were 65.4% and 63.1% for the three months ended March 31, 2018 and March 25, 2017, respectively.
Our gross margin percentages were 65.4% and 62.2% for the nine months ended March 31, 2018 and March 25, 2017, respectively.
Research and development expenses were $114.4 million and $113.2 million for the three months ended March 31, 2018 and March 25, 2017, respectively, which represented 17.6% and 19.4% of net revenues for each respective period.
Research and development expenses were $338.9 million and $340.0 million for the nine months ended March 31, 2018 and March 25, 2017, respectively, which represented 18.3% and 20.1% of net revenues for each respective period.


item4.txt
31.1Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act
31.2Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act


part2.txt
31.1Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act
31.2Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act


